Literature DB >> 22111084

Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1.

Hwan Namgung1.   

Abstract

Multiple jejunalgastrointestinal stromal tumors (GISTs) were found in a 52-year-old woman with a history of neurofibromatosis type 1. These tumors were composed of interlacing fascicles of uniform spindle cells with eosinophilic cytoplasm. Immunohistochemically, the tumor cells were positive for CD117, CD34 and negative for S-100, smooth muscle actin. Molecular analysis for activating mutations of KIT and PDGFRA was performed in two tumors. Contrary to sporadic GISTs, the NF1-associated GISTs are characterized by rare mutations of KIT or PDGFRA. But, one missense point mutation (Trp557Gly) was identified in KIT exon 11 of the extramural portion of the largest tumor in this case. The intramural portion of the largest tumor and the other tumor had wild type KIT and PDGFRA.

Entities:  

Keywords:  Gastrointestinal stromal tumors; KIT; Mutation; Neurofibromatosis type 1

Year:  2011        PMID: 22111084      PMCID: PMC3219854          DOI: 10.4174/jkss.2011.81.4.276

Source DB:  PubMed          Journal:  J Korean Surg Soc        ISSN: 1226-0053


  10 in total

1.  Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Authors:  Jae-Lyun Lee; Jin Young Kim; Min-Hee Ryu; Hye Jin Kang; Heung Moon Chang; Tae-Won Kim; Hyoungnam Lee; Ji Hyun Park; Hee Cheol Kim; Jung Sun Kim; Yoon-Koo Kang
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

2.  Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

Authors:  Markku Miettinen; John F Fetsch; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

3.  Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Authors:  Yutaka Takazawa; Shinji Sakurai; Yuji Sakuma; Tatsuru Ikeda; Jun Yamaguchi; Yoshio Hashizume; Shigeo Yokoyama; Atsushi Motegi; Masashi Fukayama
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

4.  Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.

Authors:  Shih-Ping Cheng; Ming-Jer Huang; Tsen-Long Yang; Chin-Yuan Tzen; Chien-Liang Liu; Tsang-Pai Liu; Shu-Ching Hsiao
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 5.  Genetic aberrations of gastrointestinal stromal tumors.

Authors:  Jilong Yang; Xiaoling Du; Alexander J F Lazar; Raphael Pollock; Kelly Hunt; Kexin Chen; Xishan Hao; Jonathan Trent; Wei Zhang
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

Authors:  Chiara Mussi; Hans-Ulrich Schildhaus; Alessandro Gronchi; Eva Wardelmann; Peter Hohenberger
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

7.  Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.

Authors:  Ophélia Maertens; Hans Prenen; Maria Debiec-Rychter; Agnieszka Wozniak; Raf Sciot; Patrick Pauwels; Ivo De Wever; Joris R Vermeesch; Thomas de Raedt; Anne De Paepe; Frank Speleman; Allan van Oosterom; Ludwine Messiaen; Eric Legius
Journal:  Hum Mol Genet       Date:  2006-02-06       Impact factor: 6.150

Review 8.  Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.

Authors:  J Lasota; M Miettinen
Journal:  Histopathology       Date:  2008-02-28       Impact factor: 5.087

Review 9.  Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.

Authors:  J S Koh; J Trent; L Chen; A El-Naggar; K Hunt; R Pollock; W Zhang
Journal:  Histol Histopathol       Date:  2004-04       Impact factor: 2.303

10.  Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.

Authors:  Rhonda K Yantiss; Andrew E Rosenberg; Lisa Sarran; Peter Besmer; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

  10 in total
  4 in total

1.  Oncologic manifestations of neurofibromatosis type 1 in Korea.

Authors:  Eui Tae Kim; Hwan Namgung; Hyun Deok Shin; Soon Il Lee; Jee Eun Kwon; Myung Chul Chang; Dong Guk Park
Journal:  J Korean Surg Soc       Date:  2012-03-27

2.  Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis.

Authors:  Liang Zong; Ping Chen
Journal:  World J Surg Oncol       Date:  2014-03-28       Impact factor: 2.754

3.  Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs.

Authors:  Jinchun Wu; Haiyan Zhou; Xiaoping Yi; Qiongzhi He; Tianxiang Lei; Fengbo Tan; Heli Liu; Bin Li
Journal:  Cancer Manag Res       Date:  2021-01-12       Impact factor: 3.989

4.  Gastrointestinal Stromal Tumors with KIT Mutation Coexisting with Wild-type Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1.

Authors:  Yang Li; Zhi-Dong Gao; Xiao-Dong Yang; Ying-Jiang Ye; Shan Wang; Ke-Wei Jiang
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.